Vistagen Therapeutics, Inc. VTGN Q2 2025 earnings

FAQ

When did Vistagen Therapeutics, Inc. report Q2 2025 earnings?

Vistagen Therapeutics, Inc. (VTGN) reported Q2 2025 earnings on August 7, 2025 after market close.

What were Vistagen Therapeutics, Inc.'s Q2 2025 revenue and EPS?

Vistagen Therapeutics, Inc. reported revenue of $244.0K and eps of $-0.47 for Q2 2025.

Did Vistagen Therapeutics, Inc. beat estimates in Q2 2025?

Revenue beat the consensus estimate of $215.7K by $28.3K. EPS beat the consensus estimate of $-0.47 by $0.00.

How did Vistagen Therapeutics, Inc.'s Q2 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 190.5% from $84.0K a year earlier and eps declined 34.3% from $-0.35.

Where can I find Vistagen Therapeutics, Inc.'s Q2 2025 SEC filings?

You can read the 8-K earnings release (0001411685-25-000062) and the 10-Q periodic report (0001411685-25-000064) directly on SEC EDGAR. The filing index links above go to sec.gov.